Suchergebnisse - "Liu, Yan-Hui"

PubPharm (14)

1

Precision medicine based on circulating cell-free DNA in maternal blood : there is still a long way to go

enthalten in: American journal of obstetrics and gynecology | 2023

von Liu, Y. | Lin, X. | Li, D.

2

The significance of preoperative hematological inflammatory markers in patients with meningiomas

enthalten in: Clinical neurology and neurosurgery | 2019

von Liang, R. | Li, M. | Li, J. | +3

3

Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines

enthalten in: Breast cancer research and treatment | 2017

von Xu, F. | Wang, K. | Xu, J. | +9

CommentIn: Breast Cancer Res Treat. 2018 Feb;167(3):823. - PMID 29063311

4

Circulating miR-128 as a potential diagnostic biomarker for glioma

enthalten in: Clinical neurology and neurosurgery | 2017

von Liang, R. | Li, M. | Yang, Y. | +3

5

Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness

enthalten in: Cancer medicine | 2016

von Xu, F. | Liu, Y. | Luo, X. | +10

6

Genetic risk of extranodal natural killer T-cell lymphoma : a genome-wide association study

enthalten in: The Lancet. Oncology | 2016

von Li, Z. | Xia, Y. | Feng, L. | +43

CommentIn: Lancet Oncol. 2016 Sep;17(9):1176-7. - PMID 27470080

7

Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups

enthalten in: Diagnostic pathology | 2013

von Zhang, F. | Yan, L. | Lin, S. | +10

8

Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS

enthalten in: Hepatobiliary & pancreatic diseases international : HBPD INT | 2013

von Duan, Y. | Li, D. | Liu, Y. | +5

9

Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2013

von Wang, K. | Deng, Q. | Liao, N. | +6

10

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2

enthalten in: Gut | 2012

von Zheng, F. | Liao, Y. | Cai, M. | +9

ErratumIn: Gut. 2021 Oct;70(10):e7. - PMID 34497120